A phase I study of intravenous bryostatin 1 in patients with advanced cancer
- 1 August 1993
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 68 (2) , 418-424
- https://doi.org/10.1038/bjc.1993.352
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.Published by Elsevier ,2021
- Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.1992
- Immunomodulating properties of a novel series of protein kinase C activators. The bryostatins.The Journal of Immunology, 1988
- Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells.Proceedings of the National Academy of Sciences, 1987
- Activators of protein kinase C induce myotonia by lowering chloride conductance in muscleBiochemical and Biophysical Research Communications, 1987
- PARTIAL PARALLELISM AND PARTIAL BLOCKADE BY BRYOSTATIN-1 OF EFFECTS OF PHORBOL ESTER TUMOR PROMOTERS ON PRIMARY MOUSE EPIDERMAL-CELLS1987
- Comparative effects of polymyxin B, phorbol ester and bryostatin on protein phosphorylation, protein kinase C translocation, phospholipid metabolism and differentiation of HL60 cellsBiochemical and Biophysical Research Communications, 1987
- Bryostatins mimic the effects of phorbol esters in intact human plateletsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
- DIFFERENTIAL-EFFECTS OF VARIOUS PROTEIN-KINASE-C ACTIVATORS ON PROTEIN-PHOSPHORYLATION IN HUMAN ACUTE MYELOBLASTIC-LEUKEMIA CELL-LINE KG-1 AND ITS PHORBOL ESTER-RESISTANT SUBLINE KG-1A1987
- Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skinCarcinogenesis: Integrative Cancer Research, 1987